BOON CHENG KOK MD NPI 1255397477

NPI Details

Boon Cheng Kok, MD is a hematology and oncology internal medicine in Norfolk, VA with 29 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Boon Cheng Kok, MD NPI is 1255397477. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

5900 LAKE WRIGHT DR
NORFOLK, VA
ZIP 23502-871
Phone: (757) 466-8683
Fax: (757) 466-8892

The NPI 1255397477 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Unclassified drugs (HCPCS:J3490)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Vitamin d-3 level (HCPCS:82306)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Folic acid level, serum (HCPCS:82746)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)

The enumeration date for this NPI number is 4/25/2006 and was last updated on 4/12/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.